AI Article Synopsis
- Chondrosarcomas in the hand are uncommon, and surgical options mainly include curettage or wide resection based on the severity of the tumor.
- A study followed 13 patients with Grade 1 chondrosarcoma for about 100 months, revealing that patients who underwent curettage had a 12.5% chance of relapse, while none in the wide resection group relapsed.
- Overall, both treatment methods resulted in high percentages of normal hand function (98% for curettage and 95% for wide resection) and no systemic spread of the disease, indicating that curettage is often the better choice for preserving function in these cases.
Article Abstract
Chondrosarcomas of the hand are rare and generally treated with surgical resection. Thirteen patients with Grade 1 chondrosarcoma of the small bones of the hand were followed up for a mean of 99.8 months (range, 26-293 months). In eight patients (Group 1) curettage and reconstruction with cancellous bone was done and in five patients (Group 2) a wide resection was done. No patient experienced relapse in Group 2. In Group 1 one patient had a local relapse 18 months after intralesional resection. Using the Musculoskeletal Tumor Society score for evaluation, the clinical results showed an average of 98% and 95% of the normal function in Groups 1 and 2, respectively. None of the patients had evidence of systemic spread of the disease. With a relapse rate of 12.5% and no distant metastases after curettage, intralesional resection is the preferred method of treatment in Grade 1 chondrosarcoma of the hand, allowing the patient to avoid amputation and major loss of function.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!